Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure
Abstract Elevated fibroblast growth factor 23 (FGF23) levels are associated with adverse outcome in populations with cardiovascular disease and chronic kidney failure. It is unclear if FGF23 has significance in prognosis estimation in patients with acute heart failure (HF) when compared to tradition...
Guardado en:
Autores principales: | Anne Cornelissen, Roberta Florescu, Kinan Kneizeh, Christian Cornelissen, Vincent Brandenburg, Elisa Liehn, Alexander Schuh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3e4cc40fbeaf43d49258d67aa709c569 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum intact fibroblast growth factor 23 in healthy paediatric population
por: Stanczyk Malgorzata, et al.
Publicado: (2021) -
Lack of PTEN in osteocytes increases circulating phosphate concentrations by decreasing intact fibroblast growth factor 23 levels
por: Masanobu Kawai, et al.
Publicado: (2020) -
Ultrafiltration in Acute Heart Failure
por: Maria Rosa Costanzo
Publicado: (2019) -
Clinical Characteristics of De Novo Heart Failure and Acute Decompensated Chronic Heart Failure: Are They Distinctive Phenotypes That Contribute to Different Outcomes?
por: Wilson Matthew Raffaello, et al.
Publicado: (2021) -
Temporary Mechanical Circulatory Support in Acute Heart Failure
por: Federica Jiritano, et al.
Publicado: (2020)